NeuroTronik inks $23.1 mln

NeuroTronik, a developer of technology that helps doctors treat heart failure patients, raised $23.1 million in Series B preferred stock financing. Boston Scientific Group led the round with participation from other investors that included Hatteras Venture Partners, Synergy Life Science Partners, Lord Baltimore Investment Partners and Mountain Group Capital.

North AmericaUSBriefs